Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study of Immunoglobulin G (IgG) Dynamics Against SARS-Co

NCT05042193 is registered in ClinicalTrials.gov with Everly Health as lead sponsor.

NCT NCT05042193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05042193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study of Immunoglobulin G (IgG) Dynamics Against SARS-Co
Lead sponsor
Everly Health
Phase
Observational
Overall status
Completed
Start date
March 19, 2021
Completion date
June 14, 2022
Enrollment
1,883 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 acute respiratory disease